Receiving CE Mark approval is a critical regulatory milestone that allows medical device companies like Axonics to market their products in the European Economic Area. This approval can significantly impact the company's growth trajectory by opening up new markets and increasing revenue potential. For investors, this development is likely to be viewed positively, as it demonstrates the company's ability to navigate regulatory hurdles and expand its product offerings in key markets.